India  

CDSCO expert panel recommends Covaxin be moved out of 'clinical trial mode'

IndiaTimes Wednesday, 10 March 2021
An expert panel of India's central drugs authority on Wednesday recommended granting emergency use authorisation to Bharat Biotech's indigenously developed Covaxin while removing the condition for the vaccine to be administered in 'clinical trial mode', official sources said.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Central Drugs Standard Control Organisation Central Drugs Standard Control Organisation

Import licences for foreign vaccine in 3 days, says government

“The CDSCO (Central Drugs Standard Control Organisation) will process applications for registration certificate (registration of oversees manufacturing site..
IndiaTimes

Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines

The Central Drugs Standards Control Organisation (CDSCO) headed by Drugs Controller General of India (DCGI) has explained that it prepare detailed guidelines..
IndiaTimes

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Even as Covid vaccine demand rises, firms may take some weeks to up production

Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
IndiaTimes

Related videos from verified sources

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech [Video]

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN..

Credit: ANI     Duration: 01:42Published
They thought they got the Covid-19 vaccine. They were part of a trial instead [Video]

They thought they got the Covid-19 vaccine. They were part of a trial instead

More than a dozen slum residents in Bhopal, India, say they thought they were being vaccinated for Covid-19. They say they later discovered from local activists that some of them hadn’t been given an..

Credit: Bleacher Report AOL     Duration: 03:42Published

Related news from verified sources

PM Modi's mother receives first dose of Covid-19 vaccine

Prime Minister Narendra Modi's mother, Heeraben Modi, received her first dose of the Covid-19 vaccine on Thursday. "Happy to share that my mother has taken the...
IndiaTimes Also reported by •Zee News

No shortage of Covid vaccine doses in any state in India, clarifies health ministry

The Union Health Ministry on Thursday clarified that there is no shortage of Covid-19 vaccine doses in any state in the country so far. Responding to a question...
IndiaTimes Also reported by •Zee News

Vaccine is fine, but mask is must: CCMB chief

The Covid-19 vaccine is not the end of the coronavirus story, especially with the threat of a new strain of the virus looming large across the globe, a top...
IndiaTimes